Keith B. Marschke

Publications by Year

Research Areas

Estrogen and related hormone effects, Hormonal and reproductive studies, Bioactive Compounds and Antitumor Agents, Prostate Cancer Treatment and Research, Inflammatory mediators and NSAID effects

Most-Cited Works

• → Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*(1995)1,458 cited
• → Synthesis and Biological Activity of a Novel Series of Nonsteroidal, Peripherally Selective Androgen Receptor Antagonists Derived from 1,2-Dihydropyridono[5,6-g]quinolines(1998)142 cited
• → An Orally Active Selective Androgen Receptor Modulator Is Efficacious on Bone, Muscle, and Sex Function with Reduced Impact on Prostate(2006)136 cited
• → 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: A Novel Class of Potent, Selective, and Orally Active Nonsteroidal Progesterone Receptor Antagonists(2002)106 cited
• → Estrogen Receptor β Activates the Human Retinoic Acid Receptorα -1 Promoter in Response to Tamoxifen and Other Estrogen Receptor Antagonists, but Not in Response to Estrogen(1999)103 cited
• → Androgen Receptor-Mediated Antagonism of Estrogen-Dependent Low Density Lipoprotein Receptor Transcription in Cultured Hepatocytes(1997)85 cited
• → Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)(1999)83 cited
• → Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo.(1992)79 cited
• → Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.(1994)79 cited
• → New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone(1998)78 cited